Transdermal patch

Starton Therapeutics Announces STARTICLES Filing

Retrieved on: 
Wednesday, January 17, 2024
Patient, Therapy, Patent, API, Transdermal patch, Skin, Solubility, Food, Toxicity, BCS, Invention, New product development

STARTICLES, referring to proprietary and novel solid-state particulates suspended within a drug-in-adhesive patch for delivery of active pharmaceutical ingredients (API) developed by Starton Therapeutics.

Key Points: 
  • STARTICLES, referring to proprietary and novel solid-state particulates suspended within a drug-in-adhesive patch for delivery of active pharmaceutical ingredients (API) developed by Starton Therapeutics.
  • STARTICLES is complimentary to Starton’s STARSILON platform technology which the Company launched earlier this month.
  • PARAMUS, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company transforming standard of care therapies with proprietary dermal technologies, announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for Solid State Active Pharmaceutical Composition for Transdermal Drug Delivery, referred to by the Company as STARTICLES.
  • Starton retains full global ownership of the provisional patent applications with the technology and methodology being developed internally.

United States Transdermal Patch Market Report 2023: Dosage, Price & Clinical Trials Insights to 2029 - Focus on Opioid, Cardiovascular Diseases, Neurological Disorders, and Hormonal Therapy - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 23, 2023
Medical Devices, Health, Gastritis, Brown University, Transdermal patch, Research, Indication, Chronic pain, Parkinson's disease, Pain management, Buprenorphine, University of California, Davis, Pregnancy, Patient, FDA, Alzheimer's disease, Opioid use disorder, Zydus Lifesciences, University, Cancer, Communication, Pain, Growth, Nerve, DSM-IV codes, Generic drug, Pharmaceutical industry, Adhesive, Birth control

The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.
  • With the rapid approvals of transdermal patches lately, the FDA has also marked itself as an important player in the US market of transdermal patches.
  • The FDA provides a detailed communication on the requirements of an ideal transdermal patch, and patches that meet these are allowed entry in the regional market.
  • US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 Report Highlights:
    US Transdermal Patch Market Opportunity: > US$ 5 Billion By 2029
    Commercially available Patches In US Market: > 25 Patches
    Ongoing Clinical Trials Of Transdermal Patches in US: > 40 Patches
    US Transdermal Patch Clinical Trials Insight By Company, Indication & Phase

Global Transdermal Drug Delivery Market to Reach $131.2 Billion by 2027

Retrieved on: 
Saturday, January 21, 2023
COVID-19, Transdermal patch, Active, Growth, Drug, Pharmaceutical industry

DUBLIN, Jan. 21, 2023 /PRNewswire/ -- The "Transdermal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 21, 2023 /PRNewswire/ -- The "Transdermal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • In the changed post COVID-19 business landscape, the global market for Transdermal Drug Delivery estimated at US$45.9 Billion in the year 2020, is projected to reach a revised size of US$131.2 Billion by 2027, growing at a CAGR of 16.2% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $13.1 Billion, While China is Forecast to Grow at 15.4% CAGR
    The Transdermal Drug Delivery market in the U.S. is estimated at US$13.1 Billion in the year 2020.
  • China, the world's second largest economy, is forecast to reach a projected market size of US$22.6 Billion by the year 2027 trailing a CAGR of 15.4% over the analysis period 2020 to 2027.

Transdermal Drug Delivery Global Market Report 2022: Featuring Antares Pharma, Bayer, Durect, Iontera, Novartis & More - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 17, 2023
Health, Pharmaceutical, Drug, Transdermal patch, Growth, Active, COVID-19, Pet

The "Transdermal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • In the changed post COVID-19 business landscape, the global market for Transdermal Drug Delivery estimated at US$45.9 Billion in the year 2020, is projected to reach a revised size of US$131.2 Billion by 2027, growing at a CAGR of 16.2% over the analysis period 2020-2027.
  • Passive, one of the segments analyzed in the report, is projected to record 14.8% CAGR and reach US$72 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $13.1 Billion, While China is Forecast to Grow at 15.4% CAGR
    The Transdermal Drug Delivery market in the U.S. is estimated at US$13.1 Billion in the year 2020.

Coronary Stents Market To Reach USD 8088 Million By 2027 With a CAGR of 3.9%| Valuates Reports

Retrieved on: 
Tuesday, December 20, 2022
USD, Device file, Medicine, Live cell imaging, Research, COVID-19, Transdermal patch, Valuation using multiples, Cryptocurrency, Telecommunication, Animal, Pet, Video game

-  The global Medical Supplies market size is projected to reach USD 329030 Million by 2028, from USD 202430 Million in 2021, at a CAGR of 7.1% during 2022-2028.

Key Points: 
  • -  The global Medical Supplies market size is projected to reach USD 329030 Million by 2028, from USD 202430 Million in 2021, at a CAGR of 7.1% during 2022-2028.
  • -  The global Disposable Medical Supplies market size is projected to reach USD 314410 Million by 2028, from USD 224050 Million in 2021, at a CAGR of 4.9% during 2022-2028.
  • -  The Medical Device Outsourcing market size is estimated to be valued at USD 74220 Million in 2021 and projected to reach USD 142960 Million by 2028, recording a CAGR of 9.7%.
  • -  The global CBCT Dental Imaging market size is projected to reach USD 438.3 million by 2028, from USD 298.9 million in 2021, at a CAGR of 5.6% during 2022-2028.

Coronary Stents Market To Reach USD 8088 Million By 2027 With a CAGR of 3.9%| Valuates Reports

Retrieved on: 
Tuesday, December 20, 2022
USD, Device file, Medicine, Live cell imaging, Research, COVID-19, Transdermal patch, Valuation using multiples, Cryptocurrency, Telecommunication, Animal, Pet, Video game

-  The global Medical Supplies market size is projected to reach USD 329030 Million by 2028, from USD 202430 Million in 2021, at a CAGR of 7.1% during 2022-2028.

Key Points: 
  • -  The global Medical Supplies market size is projected to reach USD 329030 Million by 2028, from USD 202430 Million in 2021, at a CAGR of 7.1% during 2022-2028.
  • -  The global Disposable Medical Supplies market size is projected to reach USD 314410 Million by 2028, from USD 224050 Million in 2021, at a CAGR of 4.9% during 2022-2028.
  • -  The Medical Device Outsourcing market size is estimated to be valued at USD 74220 Million in 2021 and projected to reach USD 142960 Million by 2028, recording a CAGR of 9.7%.
  • -  The global CBCT Dental Imaging market size is projected to reach USD 438.3 million by 2028, from USD 298.9 million in 2021, at a CAGR of 5.6% during 2022-2028.

Transdermal Drug Delivery Pipeline Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 16, 2022
Health, Pharmaceutical, Medical device, Transdermal patch, Pharmaceutical industry

The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
  • The publisher's Medical Devices sector report, "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Transdermal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
    The report enables you to:
    In-depth analysis of the product's current stage of development, territory and estimated launch date

World Transdermal Patch Market Research Report 2021: Focus on Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch & Matrix Patches - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 5, 2022
Health, Pharmaceutical, Smoking, Tobacco, Vaccine, National Health, Food, Planning Commission, Nicotine, Skin, Growth, Topical steroid withdrawal, Patient, Adult, Smoker, Ageing, Research, Medicine, FDA, Population, World, Geography, Transdermal patch, Food and Drug Administration, Industry, Center, World Health Organization, Pain management, Adhesive

The market is projected to show steady growth primarily attributed to the success of transdermal patches in dealing with concerns.

Key Points: 
  • The market is projected to show steady growth primarily attributed to the success of transdermal patches in dealing with concerns.
  • Transdermal Patches are stuck to the skin and provide medication to the body through the skin.
  • Pain management transdermal patch is widely used around the world to ease out joint, muscular, and other paining points.
  • The global transdermal patches market is segmented based on type, application, and geography.

Global Transdermal Drug Delivery Market to Reach $7.4 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 1, 2021
Pharmaceutical, Health, Cardiology, Medical Devices, CAGR, CNS, Growth, COVID-19, Drug delivery, Transdermal patch, Pet

The "Transdermal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Transdermal Drug Delivery, estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 5.7% CAGR
    The Transdermal Drug Delivery market in the U.S. is estimated at US$1.4 Billion in the year 2020.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$854.6 Million by the year 2027.

OnMi Transdermal Patches Give You Everything You Want and Nothing You Don’t

Retrieved on: 
Thursday, July 22, 2021
Health sciences, Pharmacology, Health, Routes of administration, Dosage forms, Transdermal patch, Gluten-free diet, Topical medication, Paraben, Tablet, Transdermal, Gluten

We developed transdermal patches that deliver naturally derivedvitamins and botanicals, said Ryan McFarlane, COO of OnMi.

Key Points: 
  • We developed transdermal patches that deliver naturally derivedvitamins and botanicals, said Ryan McFarlane, COO of OnMi.
  • Our transdermal patches allow ingredients to be absorbed topically without the filler ingredients that many pills and tabletscontain.
  • McFarlane said consumers might not realize that pills and tablets contain ingredients used as a lubricant for the machines that make them.
  • OnMi products, which only contain plant-based ingredients and vitamins, are also Non-GMO, Paraben Free, Dye Free, Gluten Free, and Latex Free.